Vernal keratoconjunctivitis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Mar 2026SANDIMMUNE: New indication approved
FDAcompleted
Mar 2026SANDIMMUNE: New indication approved
FDAcompleted
Mar 2026A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

Laboratoires Thea — PHASE2

TrialNOT YET RECRUITING
Dec 20253% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis

The University of Hong Kong — PHASE3

TrialNOT YET RECRUITING
Sep 2025Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis

Sohag University — NA

TrialNOT YET RECRUITING
Jun 2025Corneal Topography in Vernal Keratoconjunctivitis

Assiut University

TrialNOT YET RECRUITING
Mar 2025Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical Steroids

Superior University

TrialACTIVE NOT RECRUITING
Feb 2025Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis

Mohsen Pourazizi — PHASE1

TrialNOT YET RECRUITING
Sep 2023SANDIMMUNE: New indication approved
FDAcompleted
Mar 2022SANDIMMUNE: New indication approved
FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

4 programs

FINANCIAL LANDSCAPE SUMMARY

4

Total programs

4

Open now

4

Copay cards

Copay Assistance4

Alomide Ophthalmic Solution

Alcon Laboratories, Inc.

OpenContact for details

Verkazia

Harrow

OpenContact for detailsApply ↗

Cyclosporine

Novartis

OpenContact for detailsApply ↗

Opticrom 4% ophthalmic solution

Fisons Corporation

OpenContact for details

View all support programs on disease page →

Approved Treatments

3 FDA-approved

Verkazia

(cyclosporine)Orphan drug

Harrow Eye, LLC

Calcineurin Inhibitor Immunosuppressant [EPC]

Approved Jun 2021FDA label ↗

Alomide Ophthalmic Solution

(Lodoxamide tromethamine)Orphan drug

Alcon Laboratories, Inc.

Approved Sep 1993

Opticrom 4% ophthalmic solution

(Cromolyn sodium 4% ophthalmic solution)Orphan drug

Fisons Corporation

Approved Oct 1984

View full treatment details on disease page →

Clinical Trial Landscape

1 active trial
1Unknown
1Total recruiting
Search clinical trials for Vernal keratoconjunctivitis

Recent News & Research

No recent news articles indexed yet for Vernal keratoconjunctivitis.
Search PubMed for Vernal keratoconjunctivitis

Browse all Vernal keratoconjunctivitis news →

Specialist Network

Top 6 by expertise

View all Vernal keratoconjunctivitis specialists →

Quick Actions